129 related articles for article (PubMed ID: 11981292)
1. Use, abuse, toxicity, and monitoring of pediatric psychotropic drug therapy: new issues for the new millennium.
Liebelt EL
Curr Opin Pediatr; 2002 Apr; 14(2):211-2. PubMed ID: 11981292
[No Abstract] [Full Text] [Related]
2. Mental illness and addiction issue brief: psychotropic medication and children: year end report-2004.
Rosenberg M
Issue Brief Health Policy Track Serv; 2004 Dec; ():1-7. PubMed ID: 15744950
[No Abstract] [Full Text] [Related]
3. Psychotropic drug use in very young children.
Coyle JT
JAMA; 2000 Feb; 283(8):1059-60. PubMed ID: 10697069
[No Abstract] [Full Text] [Related]
4. Safety issues in the use of methylphenidate. An American perspective.
Rappley MD
Drug Saf; 1997 Sep; 17(3):143-8. PubMed ID: 9306050
[TBL] [Abstract][Full Text] [Related]
5. Attention-deficit/hyperactivity disorder: is it common? Is it overtreated?
Wender EH
Arch Pediatr Adolesc Med; 2002 Mar; 156(3):209-10. PubMed ID: 11876662
[No Abstract] [Full Text] [Related]
6. Treatment of attention-deficit/hyperactivity disorder.
Breggin PR
JAMA; 1999 Apr; 281(16):1490-1; author reply 1491. PubMed ID: 10227316
[No Abstract] [Full Text] [Related]
7. Attention-deficit-hyperactivity disorder.
Diller LH
N Engl J Med; 1999 Jun; 340(22):1766; author reply 1767. PubMed ID: 10357639
[No Abstract] [Full Text] [Related]
8. Quillivant XR--an extended release oral suspension of methylphenidate.
Med Lett Drugs Ther; 2013 Feb; 55(1409):10-1. PubMed ID: 23381227
[No Abstract] [Full Text] [Related]
9. Safe and effective methylphenidate therapy in a pediatric patient with glaucoma.
Lewis H; Lewis J
Atten Defic Hyperact Disord; 2012 Mar; 4(1):37-9. PubMed ID: 22311620
[TBL] [Abstract][Full Text] [Related]
10. Utilization of Stimulants and Atomoxetine for Attention-Deficit/Hyperactivity Disorder among 5.4 Million Children Using Population-Based Longitudinal Data.
Furu K; Karlstad Ø; Zoega H; Martikainen JE; Bahmanyar S; Kieler H; Pottegård A
Basic Clin Pharmacol Toxicol; 2017 Apr; 120(4):373-379. PubMed ID: 27911044
[TBL] [Abstract][Full Text] [Related]
11. Transdermal methylphenidate (Daytrana) for ADHD.
Med Lett Drugs Ther; 2006 Jun; 48(1237):49-51. PubMed ID: 16785850
[No Abstract] [Full Text] [Related]
12. Are stimulants overprescribed?
Perry R; Gilbert EM; Angkustsiri K
J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269-70; author reply 270-1. PubMed ID: 10714041
[No Abstract] [Full Text] [Related]
13. [Priapism - side effect of methylphenidate].
Aktuelle Urol; 2014 Mar; 45(2):94. PubMed ID: 24700059
[No Abstract] [Full Text] [Related]
14. Methylphenidate transdermal system.
Mays DA; Findling R
J Am Acad Child Adolesc Psychiatry; 2005 Dec; 44(12):1223. PubMed ID: 16292112
[No Abstract] [Full Text] [Related]
15. Are stimulants overprescribed?
Diller LH
J Am Acad Child Adolesc Psychiatry; 2000 Mar; 39(3):269; author reply 270-1. PubMed ID: 10714040
[No Abstract] [Full Text] [Related]
16. [Efficacy and safety of stimulants and non-stimulants in adults with attention deficit hyperactivity disorder (ADHD)].
Golubchik P; Sever J; Weizman A
Harefuah; 2011 Oct; 150(10):788-90, 814. PubMed ID: 22111124
[TBL] [Abstract][Full Text] [Related]
17. Methylphenidate for attention-deficit/hyperactivity disorder: The longest debate.
Levy F
Aust N Z J Psychiatry; 2016 Jul; 50(7):616-7. PubMed ID: 27066820
[No Abstract] [Full Text] [Related]
18. Drugs and children.
Pinkham JR
ASDC J Dent Child; 2002; 69(1):10. PubMed ID: 12119805
[No Abstract] [Full Text] [Related]
19. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association.
Goldman LS; Genel M; Bezman RJ; Slanetz PJ
JAMA; 1998 Apr; 279(14):1100-7. PubMed ID: 9546570
[TBL] [Abstract][Full Text] [Related]
20. Methylphenidate (Ritalin) use and abuse.
Crutchley A; Temlett JA
S Afr Med J; 1999 Oct; 89(10):1076-9. PubMed ID: 10582063
[No Abstract] [Full Text] [Related]
[Next] [New Search]
